Yang Yao
- Oncology top 2%
- Colorectal Cancer Treatments and Studies 13
- Cancer Treatment and Pharmacology 13
- Lung Cancer Research Studies 13
- Bone health and treatments 12
-
- Sarcoma Diagnosis and Treatment 49
- Lung Cancer Treatments and Mutations 17
- Cancer Research top 10%
- Internal Medicine top 10%
-
- Bone Tumor Diagnosis and Treatments 12
-
- Management of metastatic bone disease 11
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yang Yao
120 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 107
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 1.1k
- Orthopedics and Sports Medicine 180
- Cancer Research 302
- Internal Medicine 55
Countries citing papers authored by Yang Yao
This map shows the geographic impact of Yang Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Yao more than expected).
Fields of papers citing papers by Yang Yao
This network shows the impact of papers produced by Yang Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Yao. The network helps show where Yang Yao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yang Yao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 12 | |
| 2 | 2021 | 2 | |
| 3 | 2016 | 18 | |
| 4 | 2015 | 6 | |
| 5 | 2015 | 4 | |
| 6 | 2015 | 9 | |
| 7 | 2014 | 19 | |
| 8 | 2013 | 38 | |
| 9 | 2013 | 8 | |
| 10 | 2013 | 37 | |
| 11 | 2013 | 28 | |
| 12 | 2013 | 21 | |
| 13 | Magnesium isoglycyrrhizinate used in the treatment of chemotherapeutic drugs-induced acute liver dysfunction: A phase III clinical trial | 2012 | 8 |
| 14 | Clinical significances of Runx2 and Ezrin expressions in osteosarcoma | 2012 | 2 |
| 15 | 2012 | 41 | |
| 16 | 2012 | 24 | |
| 17 | 2012 | 29 | |
| 18 | 2010 | 44 | |
| 19 | Survival analysis of 71 cases of osteosarcoma with lung metastases | 2009 | 1 |
| 20 | Correlation between serum AKP and prognosis of osteosarcoma(with 69 osteosarcoma cases) | 2007 | 1 |
About Yang Yao
Yang Yao is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Internal Medicine and Rheumatology, having authored 125 papers that have together received 2.4k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (49 papers), Lung Cancer Treatments and Mutations (17 papers), Colorectal Cancer Treatments and Studies (13 papers), Cancer Treatment and Pharmacology (13 papers), Lung Cancer Research Studies (13 papers), Bone health and treatments (12 papers), Bone Tumor Diagnosis and Treatments (12 papers) and Management of metastatic bone disease (11 papers). The work is most often cited by research in Oncology (1.2k citations), Pulmonary and Respiratory Medicine (1.1k citations), Orthopedics and Sports Medicine (180 citations), Cancer Research (302 citations) and Internal Medicine (55 citations). Yang Yao has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Zan Shen, Wei‐Xiang Qi, Lina Tang, Aina He, Yuanjue Sun, Feng Lin, Daliu Min, Jingwen Wang, Hui Zhao and Yujing Huang. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE, Annals of Oncology, British Journal of Clinical Pharmacology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.